CHM.AX Chimeric Therapeutics Limited
Company Analysis
Latest News
🟢 Chimeric Therapeutics is trading 16.67% up today after recent heavy selling
Chimeric Therapeutics is trading at A$0.01, +16.67% now after recent heavy selling. • The September 4 application to quote 14,814,814 new shares may have...
🔴 Chimeric Therapeutics is trading 25% down today after continued selling
Chimeric Therapeutics is trading 25% down at A$0.01 after continued selling following the unexplained September 4, 2026 decline. - The September 4 filing...
🔴 Chimeric Therapeutics is trading 27.27% down after unexplained September 4 selling
Chimeric Therapeutics is trading at A$0.01 (-27.27%) following unexplained selling during the September 4 session; no verified company-specific announcement...
🔴 Chimeric Therapeutics is trading 18.18% down today after unexplained selling
Chimeric Therapeutics is trading 18.18% down at A$0.01 after unexplained selling during the September 3, 2026 session. - No verified company-specific...
🔴 Chimeric Therapeutics is trading 8.33% down today amid unexplained selling
Chimeric Therapeutics is trading A$0.01 (-8.33%) amid unexplained selling or a delayed reaction. - No verified company-specific announcement or trading halt...
🔴 Chimeric Therapeutics is trading 8.33% down today with no verified company-specific catalyst identified
Chimeric Therapeutics is trading 8.33% down at A$0.01 after no verified company-specific announcement was identified for September 2, 2026. - The latest...
🔴 Chimeric Therapeutics is trading 8.33% down today amid biotech-sector weakness
Chimeric Therapeutics is trading at A$0.01, with a -8.33% change, broadly consistent with biotechnology-sector weakness; XBI is down 4.24% during the regular...
🟢 Chimeric Therapeutics is trading 9.09% up today with no verified catalyst identified
Chimeric Therapeutics is trading at A$0.01, up 9.09% after rising from the September 1, 2026 close, with no new company-specific announcement or verified...
🟢 Chimeric Therapeutics is trading 22.22% up today
Chimeric Therapeutics is trading 22.22% up now at A$0.01, but no clear company-specific catalyst has been verified for September 1, 2026. - The August 19...
🟢 Chimeric Therapeutics is trading 11.11% up today — unconfirmed rebound amid clinical overhang
Chimeric Therapeutics is trading at A$0.01, up 11.11%, with the gain appearing to be an unconfirmed rebound in a highly volatile, low-priced biotech. - No new...
🔴 Chimeric Therapeutics is trading 10% down today amid pressure after CHM-2101 enrollment ceased
Chimeric Therapeutics is trading A$0.01 (-10.00%) amid pressure after August 19 news that CHM-2101 trial enrollment ceased following dose-limiting...
🔴 Chimeric Therapeutics is trading 9.09% down today
Chimeric Therapeutics is trading 9.09% down now at A$0.01 after another weak session on August 27, 2026. - No clear company-specific announcement explaining...
🔴 Chimeric Therapeutics is trading 15.38% down today
Chimeric Therapeutics is trading 15.38% down at A$0.01, with no clear company-specific announcement identified on August 27, 2026. - The latest major update,...
🟢 Chimeric Therapeutics is trading 7.69% up today with no clear company-specific announcement
Chimeric Therapeutics is trading 7.69% up at A$0.01 on August 26, 2026, with no new company-specific announcement clearly explaining the gain. - On August 19,...
🔴 Chimeric Therapeutics is trading 13.33% down today after CHM-2101 trial enrolment and dosing stopped
Chimeric Therapeutics is trading 13.33% down at A$0.01 after enrolment and dosing stopped in the CHM-2101 Phase 1 trial. - The August 19, 2026 announcement...
🔴 Chimeric Therapeutics is trading 25% down today after a second dose-limiting toxicity halted its trial
Chimeric Therapeutics is trading 25% down at A$0.01 as investors continue repricing the August 19 clinical setback after a second dose-limiting toxicity...
🔴 Chimeric Therapeutics Limited is trading 0.00% down
CHM.AX is trading at $0.02, down 0.00%.
🟢 Chimeric Therapeutics is trading 11.11% up today after stopping CHM-2101 enrolment and dosing
Chimeric Therapeutics is trading 11.11% up at A$0.02 after stopping CHM-2101 enrolment and dosing on August 19, 2026, following dose-limiting toxicity in a...
🟢 Chimeric Therapeutics is trading 11.11% up today after stopping CHM-2101 dosing over dose-limiting toxicity
Chimeric Therapeutics is trading 11.11% up at A$0.02 after stopping CHM-2101 Phase 1 enrolment and dosing on August 19, 2026, following dose-limiting toxicity...
🟢 Chimeric Therapeutics is trading 5.56% up today after stopping CHM-2101 Phase 1 enrolment and dosing
Chimeric Therapeutics is trading 5.56% up at A$0.02 following the August 19 cessation of CHM-2101 Phase 1 enrolment and dosing after dose-limiting toxicity in...